Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Preliminary phase I results for ILX-651 discussed at AACR meeting

April 15, 2002

Preclinical characterization of Ro-31-7453, a new cell cycle inhibitor

April 15, 2002

Potent inhibitors of angiogenesis derived from thrombospondin-1

April 15, 2002

Cephalon designs new inhibitors of VEGF-dependent angiogenesis with good oral antitumor activity

April 15, 2002

Prodrugs of betulinic acid or derivatives designed for the treatment of tumors, HIV

April 12, 2002

Phase Ib of TNFerade in solid tumors completes enrollment

April 12, 2002

TLK-286 enters phase II in breast cancer

April 12, 2002

Sloan-Kettering identifies novel antitumor macrocycles

April 12, 2002

Allos licenses N-Gene's chemoprotective agent BGP-15

April 12, 2002

Potent and selective MRP1 inhibitors considered promising clinical candidates

April 12, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...